Bio Essence Corp
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On December 8, 2023, the Company received notice from Sharon Mair, a member of the Company’s Board of Directors, that she resigned from the Board of Directors effective immediately.
Extracted from this filing and checked against the source text.
Sharon Mair resigned as Director at Bio Essence Corp.
On December 8, 2023, the Company received notice from Sharon Mair, a member of the Company’s Board of Directors, that she resigned from the Board of Directors effective immediately.View on SEC.gov
Bio Essence Corp entered into Stock Purchase Agreement with Newways, Inc. valued at cash consideration in the amount of Three Hundred Thousand Dollars ($300,000) (effective 2023-12-12).
On December 12, 2023, Bio Essence Corp., a California corporation (the “Company”) entered into a Stock Purchase Agreement (“SPA”) with Newways, Inc., a California corporation (“Newways”) whereby the Company agreed to sell to Newways its wholly owned subsidiary, Bio Essence Pharmaceutical, Inc. (“BEP”), in exchange for cash consideration in the amount of Three Hundred Thousand Dollars ($300,000).View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.